Where does THE Bionics Institute OF Australia rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), THE Bionics Institute OF Australia ranks #19,240 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does THE Bionics Institute OF Australia hold?

THE Bionics Institute OF Australia holds 15 US utility patents granted between 2015 and 2025, spanning 6 technology areas.

What is THE Bionics Institute OF Australia's Innovation Score?

THE Bionics Institute OF Australia has an Innovation Score of 38.7 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does THE Bionics Institute OF Australia focus on?

THE Bionics Institute OF Australia's top technology area is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy) with 11 patents, ranking #336 of 1,943 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is THE Bionics Institute OF Australia's patent grant rate increasing or decreasing?

THE Bionics Institute OF Australia's recent grant velocity is -14% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for THE Bionics Institute OF Australia's patents?

THE Bionics Institute OF Australia's patents average 19.3 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the THE Bionics Institute OF Australia patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

THE Bionics Institute OF Australia

USPTO PatentsView assignee record - 15 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, THE ranks #19,240 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 6 technology areas.

#19,240
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.7/100): 19.3
avg claims per patent: -14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19240 · Foreign Corporation #19,240 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #19,240/49,997
PHOTO-FINISH Tenova S P A
CPC-NARROW A61N · 6 areas
INNOV-THIN 38.7/100
CLAIMS-RICH 19.3 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DOWN -14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Tenova S.P.A. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How THE’s 38.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (25%) Velocity 8.9 pts (23%) Breadth 8.7 pts (22%) Claim depth 11.6 pts (30%)

Qualcomm Incorporated · highest

85
THE Bionics… · this assignee

39
3D Lighting… · lowest

7

What this shows THE's Innovation Score is 38.7/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for THE?

Each dot is one of THE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). THE’s own 19.3 claims/patent is ABOVE the 14.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

THE vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where THE's grants concentrate

THE Bionics Institute OF Australia is a focused PatentsView assignee: 6 CPC subclasses with 73.3% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2017. By volume, THE sits between Tenova S.P.A. and THE NEW Genius (SZ) Technology Co., Limited.

THE's three-year grant acceleration

THE Bionics Institute OF Australia shows 4 grants in 2022–2024 against only 3 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Tenova S P A

15
Teraxion

15
Tessco Communicat…

15
TGR Construction

15
THE Comfort Compa…

15
THE Commonwealth…

15
THE Janger

15
THE NEW Genius (S…

15
THE Bionics Insti… ◀

15

What this shows THE holds 15 patents at rank #19,223, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #19,223 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in THE's primary technology class.

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

THE Bionics Institute OF Australia patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	13.3%
2016	2	13.3%
2017	1	6.7%
2018	1	6.7%
2019	1	6.7%
2020	1	6.7%
2021	1	6.7%
2022	2	13.3%
2024	2	13.3%
2025partial year	2	13.3%

Which technologies does THE Bionics Institute OF Australia patent most?

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 11

A61B - DIAGNOSIS; SURGERY; Identification 8

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 2

B82Y - Specific Uses OR Applications OF NANOSTRUCTURES; Measurement OR Analysis OF NANOSTRUCTURES; Manufacture OR Treatment OF Nanostructures 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

G09B - Educational OR Demonstration APPLIANCES; Appliances FOR Teaching, OR Communicating With, THE Blind, Deaf OR MUTE; MODELS; PLANETARIA; GLOBES; MAPS; Diagrams 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

THE Bionics Institute OF Australia's patent record in context - here's where to go next.

THE Bionics Institute OF Australia's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 73.3% of its portfolio - see every assignee active in that class. Explore A61N
Ranked #19,240 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare THE Bionics Institute OF Australia against Tenova S.P.A., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.